⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VBIO News
Valion Bio, Inc. Common Stock
Form 8-K
sec.gov
VBIO
Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
accessnewswire.com
VBIO
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
accessnewswire.com
VBIO